Savara Inc
SVRA$544M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaAUSTIN
Drugs in Pipeline
4
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
SVRA News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Vancomycin inhalation powder
MRSA
Molgramostim
Autoimmune Pulmonary Alveolar Proteinosis
Inhaled molgramostim
Mycobacterium Infections, Nontuberculous
Vancomycin hydrochloride inhalation powder
Cystic Fibrosis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Vancomycin inhalation powder | Phase 3 | MRSA | - | - |
Molgramostim | Phase 3 | Autoimmune Pulmonary Alveolar Proteinosis | - | - |
Inhaled molgramostim | Phase 2 | Mycobacterium Infections, Nontuberculous | - | - |
Vancomycin hydrochloride inhalation powder | Phase 2 | Cystic Fibrosis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply